The Adrenal Glands - SciAm2012

submitted by: RalucaEllis

A humorous and educational look at the function of the adrenal glands.

Maternal Polyunsaturated Fatty Acid Status but not Prenatal Methylmercury exposure is associated with Children’s Language Functions at Age Five Years in the Seychelles

submitted by: msmulhern
Evidence from the Seychelles Child Development Nutrition Study suggests that maternal nutritional status can modulate the relationship between prenatal methylmercury (MeHg) exposure and developmental outcomes in children. The aim of this study was to investigate whether maternal PUFA status was a confounding factor in any possible associations between prenatal MeHg exposure and developmental outcomes at 5 y of age in the Republic of Seychelles. Maternal status of (n-3) and (n-6) PUFA were...
Authors: JJ Strain, Philip W Davidson, Sally W Thurston, Donald Harrington, Maria S Mulhern, Alison J McAfee, Edwin van Wijngaarden, Conrad F Shamlaye, Juliette Henderson, Gene E Watson, Grazyna Zareba, Deborah A Cory-Slechta, Miranda Lynch, Julie M W Wallace, Emeir M McSorley, Maxine P Bonham, Abbie Stokes-Riner, Jean Sloan-Reeves, Joanne Janciuras, Rosa Wong

Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation

submitted by: WentzMR
Dr. Roxana Dronca, a Medical Oncologist, Senior Associate Consultant, and Assistant Professor of Oncology at Mayo Clinic in Rochester, MN, discusses her article appearing in the October 2012 issue of Mayo Clinic Proceedings where she confirms the need for continued vigilance for brain metastases in patients with BRAF mutated metastatic melanoma, despite simultaneous successful response of extracranial metastases to BRAF-targeted therapy with vemurafenib. Available at:...

Antiepileptic Drugs 2012: Recent Advances and Trends.

submitted by: WentzMR

Dr. Joseph Sirven, Professor of Neurology from Mayo Clinic in Phoenix, AZ, reviews his article appearing in the September 2012 issue of Mayo Clinic Proceedings, where he discusses 25 newly approved medications and 3 trends to aid in making the best clinical decisions for patients with epilepsy.
Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00678-7/fulltext

TREATMENT OF NIGHTMARES WITH PRAZOSIN: A SYSTEMATIC REVIEW

submitted by: WentzMR

Dr. Simon Kung, Psychiatrist and Assistant Professor of Psychiatry and Psychology at Mayo Clinic in Rochester, MN, discusses his article appearing in the November 2012 issue of Mayo Clinic Proceedings, which elucidates the success of the drug Prazosin in reducing or eliminating the adrenalin storm in patients experiencing trauma nightmares.
Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00667-2/fulltext

Wireless Fast-Scan Cyclic Voltammetry to Monitor Adenosine in Patients With Essential Tremor During Deep Brain Stimulation

submitted by: WentzMR
Dr. Kendall Lee, a Neurosurgeon and the Director of the Neural Engineering Laboratory at Mayo Clinic in Rochester, MN, discusses his article appearing online ahead of print and in the August 2012 issue of Mayo Clinic Proceedings, which discloses a new discovery in the reaction of the brain during deep-brain-stimulation which may lead to novel treatments for neurological and psychological disorders. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00552-6/fulltext